Terms ending in 2032
Every in-force patent on Hoffmann-La Roche Inc.'s record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,779,150 | Novel Processes for the manufacture of Propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 10,702,800 | Separation Apparatus and Use Thereof In force · Medium confidence | Hoffmann-La Roche Inc. | In force | Medium confidence | |
| US 11,697,079 | Separation Apparatus and Use Thereof In force · Medium confidence | Hoffmann-La Roche Inc. | In force | Medium confidence | |
| US 12,274,960 | Separation Apparatus and Use Thereof In force · Low confidence | Hoffmann-La Roche Inc. | In force | Low confidence | |
| US 10,087,237 | Isoform Enriched Antibody Preparation and Method for Obtaining It In force · Medium confidence | Hoffmann-La Roche Inc. | In force | Medium confidence | |
| US 9,464,058 | New Imidazolylketone Derivatives In force · High confidence | Cincor Pharma, Inc. | In force | High confidence | |
| US 8,945,552 | Bispecific, Bivalent ANTI-VEGF/ANTI-ANG-2 Antibodies In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 10,874,677 | Subcutaneously Administered ANTI-IL-6 Receptor Antibody In force · High confidence | Chugai Seiyaku Kabushiki Kaisha | In force | High confidence | |
| US 11,579,151 | Method to Screen High Affinity Antibody In force · Medium confidence | Hoffmann-La Roche Inc. | In force | Medium confidence | |
| US 11,241,638 | Chromatography Column Support In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| 39 more term ends in 2032 · Pro | |||||
10 of 49 patents shown. Soonest term end first, then patent number.
Pro members see all 49.
45 of these are in force and held by Hoffmann-La Roche Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.